4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000090
CHIEF OPERATING OFFICER sold 8,000 shares at an average $106.80 ($854,423)
- CHIEF OPERATING OFFICER acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wassil Jim CHIEF OPERATING OFFICER | 2024-11-01 | Option exercise 10b5-1 | +8,000 | $2.42 | $19,360 | 213,695 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-11-01 | Sale 10b5-1 | −4,955 | $106.34 | $526,920 | 208,740 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-11-01 | Sale 10b5-1 | −2,174 | $107.20 | $233,057 | 206,566 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-11-01 | Sale 10b5-1 | −631 | $108.25 | $68,303 | 205,935 | D |
| Wassil Jim CHIEF OPERATING OFFICER | 2024-11-01 | Sale 10b5-1 | −240 | $108.93 | $26,143 | 205,695 | D |
| Derivatives | |||||||
| Wassil Jim CHIEF OPERATING OFFICER | 2024-11-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 26,638 | D | ||
| Open-market sales · 8,000 sh · avg $106.80 · $854,423 | |||||||
Loading xslF345X05/wk-form4_1730763923.xml…